Villar Liste V. Dr. José Asprilla desde Israel: espero convertir a Panamá en centro de referencia de terapia génica [Internet]. La Web de la Salud; 2023 [citado el 28 de abril de 2023]. Disponible en: https://lawebdelasalud.com/dr- jose-asprilla-desde-israel-espero-convertir-a-panama-en- centro-de-referencia-de-terapia-genica/
Pearson TS, Gupta N, San Sebastian W, Imamura-Ching J, Viehoever A, Grijalvo-Perez A, et al. Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR- guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons. Nat Commun [Internet]. 2021;12(1). Disponible en: http://dx.doi.org/10.1038/s41467-021-24524-8
Rizzi S, Spagnoli C, Frattini D, Pisani F, Fusco C. Clinical features in aromatic L-amino acid decarboxylase (AADC) deficiency: A systematic review. Behav Neurol [Internet]. 2022;2022:2210555. Disponible en: http://dx.doi.org/10.1155/2022/2210555
Shapiro L. NICE: AADC deficiency therapy Upstaza to be provided at low, no cost [Internet]. AADC News. 2023 [citado el 28 de abril de 2023]. Disponible en: https://aadcnews.com/news/nice-aadc-deficiency- therapy-upstaza-be-provided-low-no-cost/
Hwu PW-L, Kiening K, Anselm I, Compton DR, Nakajima T, Opladen T, et al. Gene therapy in the putamen for curing AADC deficiency and Parkinson’s disease. EMBO Mol Med [Internet]. 2021;13(9):e14712. Disponible en: http://dx.doi.org/10.15252/emmm.202114712
